WEST CHESTER, Ohio, Nov. 29 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company and leader in cardiac surgical
ablation systems, announced today that David J. Drachman, President and Chief
Executive Officer, is scheduled to present at the BMO Capital Markets 2007
Healthcare Conference at the Millennium Broadway Hotel in New York City on
Tuesday, December 4th, at 10:00 a.m. ET.
A live web cast and recording of the presentation will be available for 30
...
WEST CHESTER, Ohio, Nov. 20 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company and leader in cardiac surgical
ablation systems, announced today that David J. Drachman, President and Chief
Executive Officer, is scheduled to present at the Piper Jaffray 19th Annual
Health Care Conference at the Pierre Hotel in New York City on Tuesday,
November 27th, at 3:00 p.m. ET.
A live web cast and recording of the presentation will be available for 30
days follow...
Highlights
Total revenues of $12.1 million - up 29% over third quarter 2006
Net loss narrows to $2.6 million - record performance
Domestic open-heart revenues of $6.7 million - up 22% over third
quarter 2006
Domestic minimally invasive product revenues of $3.5 million - up 28%
over third quarter 2006
Record international revenues of $1.8 million - up 65% over third
quarter of 2...
WEST CHESTER, Ohio, Nov 01, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- AtriCure, Inc.
(Nasdaq: ATRC), the leader in cardiac surgical ablation systems, has been
ranked 80th in North America and 1st in Ohio in Deloitte's prestigious
Technology Fast 500. The Fast 500 is a ranking of the 500 fastest-growing
technology, media, telecommunications and life sciences companies by Deloitte
& Touche USA LLP, one of the nation's leading professional services
organizations. AtriCure achieve...
WEST CHESTER, Ohio, Oct. 22 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, will release its financial
results for the quarter ended September 30, 2007 on Tuesday, November 6, 2007.
AtriCure will host a conference call at 10:00 am ET on Tuesday, November
6, 2007 to discuss third quarter 2007 results. A live web cast of the
conference call will be available online ...
WEST CHESTER, Ohio, Oct. 16 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company and leader in cardiac surgical
ablation products, today announced that results reporting on the Company's
proprietary minimally invasive products, which physicians have adopted to
treat atrial fibrillation (AF), were published in the Journal of
Cardiovascular Electrophysiology by Dr. James H. McClelland, an
electrophysiologist, and colleagues from the Oregon Heart and Vascular
...
WEST CHESTER, Ohio, Sept. 20 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the 2007 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New
York City on Wednesday, September 26, at 12:30 p.m. ET.
A live web cast and recording of the presentation ...
WEST CHESTER, Ohio, Sept. 12 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel
in San Francisco, California on Thursday, September 20, at 8:30 a.m. PT.
A live web cast and recording of ...
WEST CHESTER, Ohio, Sept. 10 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that its
Cosgrove-Gillinov Left Atrial Appendage Occlusion System was successfully
implanted during an open-heart surgical procedure performed by Professor
Michele Genoni and Dr. Sacha Salzberg of The University of Zurich in
Switzerland with the support of Dr. Marc Gillinov of...
WEST CHESTER, Ohio, Aug. 31 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the Roth Capital Partners 2007 New York Conference at The Westin New York at
Times Square on Thursday, September 6th, at 10:00 a.m. ET.
About AtriCure, Inc.
AtriCure, Inc. is a me...
WEST CHESTER, Ohio, Aug 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the Thomas Weisel Partners 2007 Healthcare Conference at the Four Seasons
Hotel in Boston on Wednesday, September 5th, at 9:45 a.m. ET.
A live Web cast and recordi...
Highlights - Total revenues increased to $12.4 million - up 28% over second quarter 2006 - Record domestic MIS revenues of $4.0 million - up 47% over second quarter 2006 - Record 83 medical centers perform MIS procedures during the quarter - Domestic open-heart revenues of $6.8 million - up 21% over second quarter 2006 - Frigitronics(R) cardiac product line acquired - expands technology platform - Isolator(R) bipolar ablation clamp system receives 510(k) clearance for cardiac use
WEST CHESTER...
WEST CHESTER, Ohio, July 24 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, will release its financial
results for the quarter ended June 30, 2007 on Thursday, August 9, 2007.
AtriCure will host a conference call at 10:00 am EDT on Thursday, August
9, 2007 to discuss second quarter 2007 results. A live Web cast of the
conference call will be available online from ...
WEST CHESTER, Ohio, July 9 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative cardiac surgical devices, announced today that its
Isolator(R) bipolar ablation clamp system has received 510(k) clearance from
the Food and Drug Administration (FDA) for the ablation of cardiac tissue.
AtriCure believes that theirs is the only bipolar radiofrequency clamp system
that has been cleared by the FDA for the...
WEST CHESTER, Ohio, July 3 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the C. E. Unterberg, Towbin Emerging Growth Opportunities Conference at the
Mandarin Oriental Hotel in New York on Wednesday, July 11th, at 2:30 p.m. ET.
About AtriCure, Inc.
AtriCure, Inc...
WEST CHESTER, Ohio, June 5 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to participate
in the Leerink Swann & Company Rhythm Revival: Atrial Fibrillation Roundtable
Conference at the Grand Hyatt New York on Wednesday, June 6th. At 2:15 p.m.
ET, Mr. Drachman will participate in a pan...
WEST CHESTER, Ohio, May 24 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, today announced that it has entered
into definitive agreements with certain institutional investors to raise $16.5
million from the private placement of 1,789,649 shares of its common stock.
Of the total private placement, 1,683,060 shares were sold at $9.15 per share,
and 106,589 shares were sold to a...
Highlights
- Record consolidated revenues of $10.8 million
- Record domestic open revenues of $6.6 million
- Full commercial release of our open Isolator Synergy(TM) ablation system
- Achievement of key regulatory milestones
WEST CHESTER, Ohio, May 10 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative...
WEST CHESTER, Ohio, April 24 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter ended March 31, 2007 on Thursday, May 10, 2007.
AtriCure will also host a Web cast and conference call at 11:00 am EDT on
May 10, 2007 to discuss first quarter 2007 results. A live Web cast of the
conference call will be available online from th...
WEST CHESTER, Ohio, March 14 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the Cowen and Company 27th Annual Health Care Conference at the Marriott
Copley Place Hotel in Boston, MA on Thursday, March 15th, at 8:45 a.m. ET.
A live Web cast and recording of the presen...
Fourth Quarter 2006 Financial Highlights
* Record quarter, consolidated revenue of $10.6 million, previous high
$9.6 million
* Record quarter, domestic open revenue of $6.3 million, previous high
$5.6 million
* Record quarter, domestic MIS revenue of $3.3 million, previous high
$2.8 million
Full Year 2006 Financial Highlights
* Consolidated revenue of $38.2 million, 24% growth
* Domestic MIS revenue of $11.0 million, 66% growth...
WEST CHESTER, Ohio, Feb. 14 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David J.
Drachman, President and Chief Executive Officer, is scheduled to present at
the Roth Capital 19th Annual OC Conference at the Ritz Carlton in Laguna
Niguel, CA on Tuesday, February 20th, at 11:00 a.m. PT.
A live Web cast and recording of the presentation will be avail...
Pulsing Electrode Pairs
Superior Performance in Thicker Tissues
More Durable Ablation Lines
WEST CHESTER, Ohio, Feb. 6 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that it has received
Food and Drug Administration 510(k) clearance for its Isolator(TM) Synergy(TM)
Bipolar Ablation...
WEST CHESTER, Ohio, Jan. 31 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter and year ended December 31, 2006 on Thursday, February 15,
2007 after the close of the U.S. financial markets.
AtriCure will also host a Web cast and conference call at 5:00 pm ET on
February 15, 2007 to discuss fourth quarter and full year 2006 r...
WEST CHESTER, Ohio, Jan. 9 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that it has hired
Julie Piton, CPA, MBA as Vice President of Finance and Administration and
Chief Financial Officer. Ms. Piton will commence employment at AtriCure on
January 23, 2007.
Prior to joining AtriCure, Ms. Piton was the Vice President of Finance and
Investor Relations at ...
